Rebound Therapeutics is a Biotechnology startup founded in 2015. The company recently secured a significant $16.50M Series B investment on 25 July 2017 from notable investors including Invus, HBM-MedFocus, Wexford Capital. This investment marks a critical milestone in the company's growth and development within the biotechnology sector. Rebound Therapeutics' innovative approach and strong investment support position the company for potential breakthroughs in the near future.
Rebound Therapeutics
Founded 2015
1001-5000 employees
Series B
Total: $16.50M
Biotechnology, Health and Wellness +1
General Information
Company Name
Rebound Therapeutics
Founded Year
2015
Employees
1001-5000
Industries
Biotechnology, Health and Wellness, Medical Devices
Funding Stage
Series B
Social
BounceWatch is an independent company data service, not affiliated with Rebound Therapeutics. To contact Rebound Therapeutics, visit reboundtx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Rebound Therapeutics compare?
A PDF of Rebound Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Rebound Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Rebound Therapeutics on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
Biotechnology
About Rebound Therapeutics
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | $16.50M | 3 |
|
25 Jul 2017 |
FAQ About Rebound Therapeutics
Rebound Therapeutics was founded in 2015.
Rebound Therapeutics operates in Biotechnology, Health and Wellness and Medical Devices.
Rebound Therapeutics has approximately 1001-5000 employees.
Rebound Therapeutics has completed 1 funding round, raising a total of $16.50M. The latest funding stage is Series B.
We're actively collecting intelligence on Rebound Therapeutics.
Source: BounceWatch company record for Rebound Therapeutics, https://bouncewatch.com/company/rebound-therapeutics, updated 12 September 2024. When citing, please name BounceWatch and link this page.
